BCLS Fund III Investments, LP

13F Holdings History for Dianthus Therapeutics, Inc. - Common Stock, $0.001 par value (DNTH)

Symbol: DNTH on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value
Latest Disclosed Ownership: 1.32M shares
Security Ownership: 3.1%

BCLS Fund III Investments, LP ownership in Dianthus Therapeutics, Inc. Common Stock, $0.001 par value (DNTH)

2025-11-14 - BCLS Fund III Investments, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.32M shares of Dianthus Therapeutics, Inc. Common Stock, $0.001 par value (DNTH). This represents 3.1% percent ownership of the company. In their previous filing dated 2025-08-14, BCLS Fund III Investments, LP had reported owning 2.48M shares, indicating a decrease of -47% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BCLS Fund III Investments, LP	3.1%	-55%	$51.8M	1.32M	-1,166,358	-47%	$39.35	13G/A	9/30/2025	14 Nov 2025 16:30:04
BCLS Fund III Investments, LP	7.5%	-14.4%	$61.6M	2.48M	-207,457	-7.71%	$24.81	13G/A	6/30/2025	14 Aug 2025 16:00:14
BCLS Fund III Investments, LP	8.8%		$42M	2.69M			$15.60	13G/A	12/31/2024	14 Feb 2025 07:54:51